Used in pharmaceutical research as a potent and selective antagonist of the CB1 cannabinoid receptor. It shows potential in studying disorders related to the endocannabinoid system, including obesity, addiction, and metabolic syndromes. Due to its high affinity and slow dissociation from the receptor, it is valuable in binding assays and receptor occupancy studies. Its adamantane-derived structure contributes to enhanced metabolic stability and blood-brain barrier penetration, making it suitable for in vivo experiments. Also employed as a chemical probe to investigate cannabinoid receptor function without activating downstream signaling pathways.